1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E9AC60578BE0C63185257BBB0068C19C
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/optimizing-digital-marketing-group-structure-and-mitigating-regulatory-risk?opendocument
18
19opendocument
2098.80.143.34
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Digital Technology » Digital Marketing Strategies

Digital Marketing Excellence: Mitigating Regulatory Risk & Optimizing Group Structure

ID: 5262


Features:

14 Info Graphics

12 Data Graphics

80+ Metrics

2 Narratives


Pages/Slides: 32


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Digital Marketing Excellence: Mitigating Regulatory Risk & Optimizing Group Structure"

STUDY OVERVIEW
Digital Marketing technologies are transforming the commercial marketplace. This is changing the communication landscape and forcing companies to develop new marketing skills that employ a broad range of new tools and techniques. This Best Practices, LLC benchmark study is designed to help companies identify and manage the regulatory risks that surround a wide variety of Digital Marketing (DM) platforms and activities. This research also delivers insights on how peer companies structure their DM groups in order to protect against regulatory issues while still pushing front-line innovation.

Research findings provide metrics that can serve as a reference point for marketing leaders seeking to create better alignment between the DM function and the rest of the organization, particularly with respect to key regulatory stakeholders.

KEY TOPICS

  • Identifying & Mitigating Top Regulatory Risks
  • Impact of Regulatory Concerns over DM Investments
  • Regulatory Risks in Using Social Media & Other Channels
  • Optimizing the Digital Marketing Function Structure for High Performance
  • Trends in DM Organizational Structures
  • Reporting Structure for Digital Marketing Function

SAMPLE KEY METRICS
  • Digital Marketing topics of greatest importance to your organization
  • How much as concern over regulatory issues impacted Digital Marketing investment at your company
  • How have you modified your behavior because of the regulatory environment
  • Rate the level of perceived regulatory risk for various forms of social media
  • What are your Best Practices for successfully using social media while avoiding regulatory risk
  • What Digital Marketing structure does your organization use in each of the following regions and markets
  • How has your Digital Marketing structure changed in the last 24 months
  • Which approaches best describe the organizational structure of Digital Marketing at your organization
  • Does your organization have a Digital Marketing center of excellence
  • What are your lessons learned for structuring the Digital Marketing function

SAMPLE KEY FINDINGS
  • Perceived Risks Are Highest on External ChannelsThough all Digital activities entail some degree of risk, the majority of companies assigned “high-risk status” only to the use of popular external social platforms like Twitter (66%), Facebook (65%), and Google Plus (52%).  Other familiar channels such as YouTube, Pinterest, and LinkedIn were rated as being as being highly or somewhat risky by at least half of respondents. 
  • Multi-Layered DM Structures Work Best for Providing Coverage to Whole OrganizationForty percent of benchmark companies use a DM structure that is decentralized either according to geography, business unit, product or some combination of these elements.  Almost the same number of organizations (37%) define their DM structure as a “Hub and Spokes” model, where a centralized Digital group works in partnership with business unit-based Digital Marketers. 
METHODOLOGY

Best Practices, LLC engaged 31 marketing leaders at 28 companies through a benchmarking survey instrument.  

Industries Profiled:
Pharmaceutical; Diagnostic; Marketing; Test Industry; Manufacturing; Professional Services; Health Care; Medical Device; Biotech; Computers; Computer Software; Utilities; Telecommunications; Consumer Products; Chemical


Companies Profiled:
Abbvie; Given Imaging; SFA Marketing; Testo; Trane; Virbac Animal Health; 3M Company; Biogen Idec; Lupin; SAS; Shire; Daiichi Sankyo; Pfizer; Valeant; Bayer; Novartis; Genomic Health; Genentech; Baxter Healthcare; Abbott; Ferring Pharmaceuticals; Dentsply International; Johnson & Johnson; Astellas; Boston Scientific; GlaxoSmithKline ; Novo Nordisk

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.